MRI guided brachytherapy in locally advanced cervix cancer. The brachytherapy boost is individually tailored according to the response of the tumour to external beam radiotherapy.

Cervix cancer is among the most frequent and deadly cancers among women worldwide. An efficient screening programme has significantly decreased the incidence in high income countries, but in low and middle income countries the incidence is predicted to rise or remain stable over the next 50 years even under the effect of HPV vaccination.

The cervix cancer radiotherapy research group at Aarhus University Hospital/the Danish Centre for Particle Therapy focus on the entire process of radiotherapy including imaging, treatment planning, treatment delivery as well as patient outcome after radiotherapy. The research group is actively involved in coordination of large international clinical studies (the EMBRACE studies) with the aim of continuously setting new international standards for radiotherapy in cervix cancer.

The research group has a large international network with other universities and collaborate with students and colleagues worldwide. Furthermore, the group has significant interest in dissemination, and has coordinated an accreditation program for the EMBRACE studies, participates in international guideline groups, and engages in international teaching courses. These activities secure the dissemination of results from the research group and have contributed to the international change of practice in cervix cancer radiotherapy happening over the last decade.


Kari Tanderup 80x120.pngProfessor of medical physics
Kari Tanderup

Further information.

Marta Pelizzola

Mayuri.pngPhD Student
Mayuri Charnalia